loadpatents
name:-0.15844011306763
name:-0.080605983734131
name:-0.01998496055603
SIEMEISTER; Gerhard Patent Filings

SIEMEISTER; Gerhard

Patent Applications and Registrations

Patent applications and USPTO patent grants for SIEMEISTER; Gerhard.The latest application filed is for "inhibitor of atr kinase for use in a method of treating a hyper-proliferative disease".

Company Profile
19.94.158
  • SIEMEISTER; Gerhard - Berlin DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibitor Of Atr Kinase For Use In A Method Of Treating A Hyper-proliferative Disease
App 20210404012 - WENGNER; Antje Margret ;   et al.
2021-12-30
Combination Of Atr Kinase Inhibitors With 2,3-dihydroimidazo[1,2-c]quinazoline Compounds
App 20210369724 - WENGNER; Antje Margret ;   et al.
2021-12-02
Combination Of Atr Kinase Inhibitors With Parp Inhibitors
App 20210128572 - WENGNER; Antje Margret ;   et al.
2021-05-06
2-(morpholin-4-yl)-1,7-naphthyridines
App 20200383991 - WORTMANN; Lars ;   et al.
2020-12-10
Predictive Markers For Atr Kinase Inhibitors
App 20200375997 - WENGNER; Antje Margret ;   et al.
2020-12-03
2-(morpholin-4-yl)-1,7-naphthyridines
Grant 10,772,893 - Wortmann , et al. Sept
2020-09-15
5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines
Grant 10,729,680 - Lucking , et al.
2020-08-04
Macrocyclic sulfondiimine compounds
Grant 10,717,749 - Lucking , et al.
2020-07-21
Hetero-1,5,6,7-tetrahydro-4h-indol-4-ones
App 20200216439 - GRAHAM; Keith ;   et al.
2020-07-09
Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases
Grant 10,604,532 - Hitchcock , et al.
2020-03-31
An Inhibitor Of Atr Kinase For Use In A Method Of Treating A Hyper-proliferative Disease
App 20200063212 - WENGNER; Antje Margret ;   et al.
2020-02-27
4H-pyrrolo[3,2-C]pyridin-4-one derivatives
Grant 10,428,063 - Graham , et al. October 1, 2
2019-10-01
3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
Grant 10,428,044 - Graham , et al. October 1, 2
2019-10-01
Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases
App 20190284206 - HITCHCOCK; Marion ;   et al.
2019-09-19
Benzyl substituted indazoles as BUB1 inhibitors
Grant 10,350,206 - Mengel , et al. July 16, 2
2019-07-16
1H-pyrrol-3-amines
Grant 10,308,629 - Graham , et al.
2019-06-04
5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines
App 20190142812 - LUCKING; Ulrich ;   et al.
2019-05-16
Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases
Grant 10,266,548 - Hitchcock , et al.
2019-04-23
3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
Grant 10,227,299 - Graham , et al.
2019-03-12
Modified macrocyclic compounds
Grant 10,214,542 - Lucking , et al. Feb
2019-02-26
Novel Modified Macrocyclic Compounds
App 20180282346 - LUCKING; Ulrich ;   et al.
2018-10-04
Novel Macrocyclic Sulfondiimine Compounds
App 20180273548 - LUCKING; Ulrich ;   et al.
2018-09-27
2-(morpholin-4-yl)-1,7-naphthyridines
App 20180256591 - WORTMANN; Lars ;   et al.
2018-09-13
1h-pyrrol-3-amines
App 20180222881 - GRAHAM; Keith ;   et al.
2018-08-09
2-(morpholin-4-yl)-1,7-naphthyridines
Grant 9,993,484 - Wortmann , et al. June 12, 2
2018-06-12
3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
App 20180155285 - GRAHAM; Keith ;   et al.
2018-06-07
Macrocyclic compounds
Grant 9,963,464 - Lucking , et al. May 8, 2
2018-05-08
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
Grant 9,962,389 - Lucking , et al. May 8, 2
2018-05-08
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
Grant 9,902,716 - Kosemund , et al. February 27, 2
2018-02-27
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
Grant 9,884,849 - Kosemund , et al. February 6, 2
2018-02-06
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Grant 9,877,954 - Lucking , et al. January 30, 2
2018-01-30
4h-pyrrolo[3,2-c]pyridin-4-one Derivatives
App 20180016272 - GRAHAM; Keith ;   et al.
2018-01-18
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
Grant 9,856,242 - Kosemund , et al. January 2, 2
2018-01-02
Compounds For The Treatment Of Cancer
App 20170342064 - SCHULZE; Volker ;   et al.
2017-11-30
Amino-substituted Isothiazoles
App 20170334899 - BARFACKER; Lars ;   et al.
2017-11-23
Benzyl Substituted Indazoles As Bub1 Kinase Inhibitors
App 20170305882 - MENGEL; Anne ;   et al.
2017-10-26
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
Grant 9,790,189 - Lucking , et al. October 17, 2
2017-10-17
Diaminoheteroaryl Substituted Indazoles
App 20170283396 - HILGER; Christoph-Stephan ;   et al.
2017-10-05
Benzyl Substituted Indazoles As Bub1 Inhibitors
App 20170273980 - MENGEL; Anne ;   et al.
2017-09-28
Heteroaryl Substituted Indazoles
App 20170275268 - HITCHCOCK; Marion ;   et al.
2017-09-28
Benzyl Substituted Indazoles As Bub1 Kinase Inhibitors
App 20170275269 - MENGEL; Anne ;   et al.
2017-09-28
Substituted Cycloalkenopyrazoles As Bub1 Inhibitors For The Treatment Of Cancer
App 20170275267 - HITCHCOCK; Marion ;   et al.
2017-09-28
Benzyl Substituted Indazoles
App 20170275270 - BARFACKER; Lars ;   et al.
2017-09-28
Sulfoximine substituted 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives and their use as CDK9 kinase inhibitors
Grant 9,770,445 - Kosemund , et al. September 26, 2
2017-09-26
Substituted benzylpyrazoles
Grant 9,765,058 - Hitchcock , et al. September 19, 2
2017-09-19
Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases
App 20170260198 - HITCHCOCK; Marion ;   et al.
2017-09-14
Heteroaryl substituted pyrazoles
Grant 9,745,285 - Mengel , et al. August 29, 2
2017-08-29
Fluorinated Benzofuranyl-pyrimidine Derivatives Containing A Suflone Group
App 20170226092 - KOSEMUND; Dirk ;   et al.
2017-08-10
2-(morpholin-4-yl)-1,7-naphthyridines
App 20170216304 - WORTMANN; Lars ;   et al.
2017-08-03
Amino-substituted Isoxazoles
App 20170217946 - BARFACKER; Lars ;   et al.
2017-08-03
Fluorinated Benzofuranyl-pyrimidine Derivatives Containing A Sulfoximine Group
App 20170217938 - KOSEMUND; Dirk ;   et al.
2017-08-03
4-aryl-n-phenyl-1,3,5-triazin-2-amines Containing A Sulfoximine Group
App 20170217949 - LUCKING; Ulrich ;   et al.
2017-08-03
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives Containing A Sulfoximine Group
App 20170202815 - LUCKING; Ulrich ;   et al.
2017-07-20
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
Grant 9,708,293 - Lucking , et al. July 18, 2
2017-07-18
Amino-substituted isothiazoles
Grant 9,682,995 - Barfacker , et al. June 20, 2
2017-06-20
Heteroaryl substituted pyrazoles
Grant 9,682,974 - Mengel , et al. June 20, 2
2017-06-20
Triazolopyridines
Grant 9,676,766 - Schulze , et al. June 13, 2
2017-06-13
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
Grant 9,670,161 - Lucking , et al. June 6, 2
2017-06-06
Substituted triazolopyridines
Grant 9,670,202 - Schirok , et al. June 6, 2
2017-06-06
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
Grant 9,669,034 - Lucking , et al. June 6, 2
2017-06-06
Substituted triazolopyridines and their use as TTK inhibitors
Grant 9,663,510 - Schulze , et al. May 30, 2
2017-05-30
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group
Grant 9,650,361 - Lucking , et al. May 16, 2
2017-05-16
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Grant 9,650,340 - Lucking , et al. May 16, 2
2017-05-16
Substituted benzylpyrazoles
Grant 9,643,953 - Hitchcock , et al. May 9, 2
2017-05-09
3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
App 20170101391 - GRAHAM; Keith ;   et al.
2017-04-13
Prodrug derivatives of substituted triazolopyridines
Grant 9,586,958 - Schulze , et al. March 7, 2
2017-03-07
Novel Macrocyclic Compounds
App 20170029439 - LUCKING; Ulrich ;   et al.
2017-02-02
Substituted triazolopyridines
Grant 9,555,022 - Schulze , et al. January 31, 2
2017-01-31
2-(morpholin-4-yl)-1,7-naphthyridines
Grant 9,549,932 - Wortmann , et al. January 24, 2
2017-01-24
Disubstituted 5-fluoro Pyrimidine Derivatives Containing A Sulfondiimine Group
App 20170015634 - LUCKING; Ulrich ;   et al.
2017-01-19
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives Containing A Sulfone Group
App 20170001989 - KOSEMUND; Dirk ;   et al.
2017-01-05
Substituted imidazopyridazines
Grant 9,512,126 - Koppitz , et al. December 6, 2
2016-12-06
Substituted imidazopyridazines
Grant 9,512,130 - Koppitz , et al. December 6, 2
2016-12-06
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
Grant 9,499,492 - Lucking , et al. November 22, 2
2016-11-22
Heteroaryl Substituted Pyrazoles
App 20160326159 - MENGEL; Anne ;   et al.
2016-11-10
Imidazopyrazines
Grant 9,468,642 - Klar , et al. October 18, 2
2016-10-18
Substituted Triazolopyridines
App 20160297811 - SCHIROK; Hartmut ;   et al.
2016-10-13
2-(morpholin-4-yl)-1,7-naphthyridines
App 20160287604 - Wortmann; Lars ;   et al.
2016-10-06
Substituted Triazolopyridines Having Activity As Mps-1 Inhibitors
App 20160264568 - SCHULZE; Volker K. ;   et al.
2016-09-15
Prodrug Derivatives Of Substituted Triazolopyridines
App 20160207915 - Schulze; Volker ;   et al.
2016-07-21
Novel Compounds For The Treatment Of Cancer
App 20160207928 - SCHULZE; Volker ;   et al.
2016-07-21
Substituted benzimidazoles
Grant 9,388,140 - Klar , et al. July 12, 2
2016-07-12
Combination Of A Imidazopyridazine Derivative And A Mitotic Agent For The Treatment Of Cancer
App 20160175306 - WENGNER; Antje Margret ;   et al.
2016-06-23
Heteroaryl Substituted Pyrazoles
App 20160168130 - HITCHCOCK; Marion ;   et al.
2016-06-16
Substituted Benzylpyrazoles
App 20160151370 - HITCHCOCK; Marion ;   et al.
2016-06-02
Heteroaryl Substituted Pyrazoles
App 20160145267 - HITCHCOCK; Marion ;   et al.
2016-05-26
Sulfoximine Substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives And Their Use As Cdk9 Kinase Inhibitors
App 20160143893 - KOSEMUND; Dirk ;   et al.
2016-05-26
Diaminoheteroaryl Substituted Pyrazoles
App 20160145239 - HILGER; Christoph-Stephan ;   et al.
2016-05-26
Heteroaryl Substituted Pyrazoles
App 20160145238 - MENGEL; Anne ;   et al.
2016-05-26
Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
Grant 9,340,528 - Bader , et al. May 17, 2
2016-05-17
Combinations For The Treatment Of Cancer Comprising A Mps-1 Kinase Inhibitor And A Mitotic Inhibitor
App 20160128988 - WENGNER; Antje Margret ;   et al.
2016-05-12
Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors
Grant 9,284,317 - Koppitz , et al. March 15, 2
2016-03-15
Diaminoheteroaryl Substituted Indazoles
App 20160052912 - HILGER; Christoph-Stephan ;   et al.
2016-02-25
Use Of (rs)-s-cyclopropyl-s-(4--5-(trifluoromethyl)pyrimidin-2-yl]amino}ph- Enyl)sulfoximide For Treatment Of Specific Tumours
App 20160045496 - SIEMEISTER; Gerhard ;   et al.
2016-02-18
3-heteroaryl Substituted Indazoles
App 20160046610 - HITCHCOCK; Marion ;   et al.
2016-02-18
Heteroaryl Substituted Indazoles
App 20160046604 - HITCHCOCK; Marion ;   et al.
2016-02-18
Substituted imidazopyridazines
Grant 9,255,100 - Klar , et al. February 9, 2
2016-02-09
Substituted Imidazopyridazines
App 20160016959 - Koppitz; Marcus ;   et al.
2016-01-21
Amino-substituted Isothiazoles
App 20150368260 - BARFACKER; Lars ;   et al.
2015-12-24
6-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitors
Grant 9,212,184 - Koppitz , et al. December 15, 2
2015-12-15
Substituted imidazopyrazines
Grant 9,199,999 - Klar , et al. December 1, 2
2015-12-01
N-(pyridin-2-yl)pyrimidin-4-amine Derivatives Containing A Sulfoximine Group
App 20150291559 - Lucking; Ulrich ;   et al.
2015-10-15
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl Amines Containing A Sulfoximine Group
App 20150291537 - Lucking; Ulrich ;   et al.
2015-10-15
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives Containing A Sulfoximine Group
App 20150291528 - Lucking; Ulrich ;   et al.
2015-10-15
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives Containing A Sulfone Group
App 20150274666 - Lucking; Ulrich ;   et al.
2015-10-01
N-(pyridin-2-yl)pyrimidin-4-amine Derivatives Containing A Sulfone Group
App 20150274695 - Lucking; Ulrich ;   et al.
2015-10-01
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl Amines Containing A Sulfone Group
App 20150259300 - Lucking; Ulrich ;   et al.
2015-09-17
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
Grant 9,133,171 - Lucking , et al. September 15, 2
2015-09-15
Disubstituted 5-fluoro-pyrimidines
Grant 9,108,926 - Lucking , et al. August 18, 2
2015-08-18
Substituted Triazolopyridines And Their Use As Ttk Inhibitors
App 20150210683 - Schulze; Volker ;   et al.
2015-07-30
Substituted Cycloalkenopyrazoles As Bub1 Inhibitors For The Treatment Of Cancer
App 20150141372 - Hitchcock; Marion ;   et al.
2015-05-21
Substituted Imidazopyridazines
App 20150104526 - Koppitz; Marcus ;   et al.
2015-04-16
Substituted sulphonamido phenoxybenzamides
Grant 8,993,630 - Hartung , et al. March 31, 2
2015-03-31
Disubstituted 5-fluoro Pyrimidine Derivatives Containing A Sulfoximine Group
App 20150005329 - Lucking; Ulrich ;   et al.
2015-01-01
Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines
Grant 8,916,557 - Lucking , et al. December 23, 2
2014-12-23
4-aryl-n-phenyl-1,3,5-triazin-2-amines Containing A Sulfoximine Group
App 20140315906 - Lucking; Ulrich ;   et al.
2014-10-23
Substituted Benzylpyrazoles
App 20140315934 - Hitchcock; Marion ;   et al.
2014-10-23
Substituted Benzimidazoles
App 20140302010 - Klar; Ulrich ;   et al.
2014-10-09
Substituted Imidazopyridines And Intermediates Thereof
App 20140255392 - Koppitz; Marcus ;   et al.
2014-09-11
Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases
App 20140249133 - Hitchcock; Marion ;   et al.
2014-09-04
Disubstituted 5-fluoro-pyrimidines
App 20140228387 - Lucking; Ulrich ;   et al.
2014-08-14
Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicine
Grant 8,802,686 - Lucking , et al. August 12, 2
2014-08-12
Use Of Ccne2 As A Stratification Marker In The Treatment Of Breast Tumours With Novel Pan-cdk Inhibitors
App 20140221243 - Siemeister; Gerhard ;   et al.
2014-08-07
Use Of Mad2l2 As A Stratification Marker In The Treatment Of Breast Tumours With Novel Pan-cdk Inhibitors
App 20140200233 - Siemeister; Gerhard ;   et al.
2014-07-17
6 Substituted Imidazopyrazines For Use As Mps-1 And Tkk Inhibitors In The Treatment Of Hyperproliferative Disorders
App 20140187548 - Koppitz; Marcus ;   et al.
2014-07-03
Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine
Grant 8,735,412 - Lucking , et al. May 27, 2
2014-05-27
Substituted imidazoquinoxalines
Grant 8,729,082 - Koppitz , et al. May 20, 2
2014-05-20
6-substituted Imidazopyrazines For Use As Mps-1 And Tkk Inhibitors In The Treatment Of Hyperproliferative Disorders
App 20140135319 - Koppitz; Marcus ;   et al.
2014-05-15
Triazolopyridines
App 20140120087 - Schulze; Volker ;   et al.
2014-05-01
Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
App 20140045852 - Lucking; Ulrich ;   et al.
2014-02-13
Substituted Imidazopyridazines
App 20130338133 - Klar; Ulrich ;   et al.
2013-12-19
Imidazopyrazines For Use As Mps-1 And Tkk Inhibitors In The Treatment Hyperproliferative Disorders
App 20130303532 - Koppitz; Marcus ;   et al.
2013-11-14
6-thio-substituted Imidazopyrazines For Use As Mps-1 And Tkk Inhibitors In The Treatment Of Hyperproliferative Disorders
App 20130281460 - Koppitz; Marcus ;   et al.
2013-10-24
Substituted 6-imidazopyrazines For Use As Mps-1 And Tkk Inhibitors In The Treatment Of Hyperproliferative Disorders
App 20130267527 - Koppitz; Marcus ;   et al.
2013-10-10
Substituted triazolopyridines
Grant 8,551,980 - Schulze , et al. October 8, 2
2013-10-08
Substituted tricyclic compounds and methods of use thereof
Grant 8,524,722 - Schirok , et al. September 3, 2
2013-09-03
Substituted Imidazopyrazines
App 20130210815 - Klar; Ulrich ;   et al.
2013-08-15
Use Of Novel Pan-cdk Inhibitors For Treating Tumors
App 20130210846 - Lucking; Ulrich ;   et al.
2013-08-15
Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents
Grant 8,507,510 - Lucking , et al. August 13, 2
2013-08-13
Imidazopyrazines
App 20130195848 - Klar; Ulrich ;   et al.
2013-08-01
2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor action
Grant 8,492,570 - Hillisch , et al. July 23, 2
2013-07-23
Substituted Triazolopyridines
App 20130156756 - Schulze; Volker ;   et al.
2013-06-20
Triazolopyridine Derivatives
App 20130121994 - Koppitz; Marcus ;   et al.
2013-05-16
Substituted Triazolopyridines
App 20120328611 - Schulze; Volker ;   et al.
2012-12-27
Triazolopyridines
App 20120328610 - Schulze; Volker ;   et al.
2012-12-27
Substituted Aminoquinoxalines As Tyrosine Threonine Kinase Inhibitors
App 20120263708 - Bader; Benjamin ;   et al.
2012-10-18
Substituted Halophenoxybenzamide Derivatives
App 20120263714 - Hitchcock; Marion ;   et al.
2012-10-18
Substituted Imidazoquinoxalines
App 20120128662 - Koppitz; Marcus ;   et al.
2012-05-24
Sulfoximine-substituted Anilinopyrimidine Derivatives As Cdk Inhibitors, The Production Thereof, And Use As Medicine
App 20110294838 - Lucking; Ulrich ;   et al.
2011-12-01
Sulfone-substituted Anilinopyrimidine Derivatives As Cdk Inhibitors, The Production Thereof, And Use As A Medicine
App 20110251222 - Lucking; Ulrich ;   et al.
2011-10-13
Substituted Sulphonamido Phenoxybenzamides
App 20110218219 - Hartung; Ingo ;   et al.
2011-09-08
Sulphimides as protein kinase inhibitors
Grant 7,943,629 - Luecking , et al. May 17, 2
2011-05-17
Antitumoral D-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates
Grant RE42,132 - Hillisch , et al. February 8, 2
2011-02-08
Substituted Tricyclic Compounds And Methods Of Use Thereof
App 20110021493 - Schirok; Hartmut ;   et al.
2011-01-27
Sulfoximine-substituted Pyrimidines As Cdk- And/or Vegf Inhibitors, Their Production And Use As Pharmaceutical Agents
App 20100076000 - Lucking; Ulrich ;   et al.
2010-03-25
Metasubstituted Thiazolidinones, Their Manufacture And Use As A Drug
App 20100048891 - SCHULZE; Klause ;   et al.
2010-02-25
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
Grant 7,598,260 - Brumby , et al. October 6, 2
2009-10-06
2-substituted Estra-1,3,5(10)-triene-3-yl Sulfamate With An Anti-tumour Action
App 20090221841 - HILLISCH; Alexander ;   et al.
2009-09-03
Thiazolidinones, their production and use as pharmaceutical agents
Grant 7,511,059 - Schulze , et al. March 31, 2
2009-03-31
N-Aryl-sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
Grant 7,456,191 - Luecking , et al. November 25, 2
2008-11-25
2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action
Grant 7,427,610 - Hillisch , et al. September 23, 2
2008-09-23
Novel Hetaryl-phenylenediamine-pyrimidines As Protein Kinase Inhibitors
App 20080176866 - Jautelat; Rolf ;   et al.
2008-07-24
New effector conjugates, process for their production and their pharmaceutical use
App 20080166362 - Berger; Markus ;   et al.
2008-07-10
Carbamoylsulphoximides as protein kinase inhibitors
App 20080167330 - Luecking; Ulrich ;   et al.
2008-07-10
Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
Grant 7,378,406 - Hoffmann , et al. May 27, 2
2008-05-27
Sulphimides As Protein Kinase Inhibitors
App 20080058358 - Luecking; Ulrich ;   et al.
2008-03-06
Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
Grant 7,338,958 - Luecking , et al. March 4, 2
2008-03-04
Effector conjugates, process for their production and their pharmaceutical use
Grant 7,335,775 - Berger , et al. February 26, 2
2008-02-26
CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents
App 20080039447 - Brumby; Thomas ;   et al.
2008-02-14
Substituted Isoxazolines, Pharmaceutical Compositions Containing Same, Methods Of Preparing Same, And Uses Of Same
App 20080027059 - Brittain; Dominic E.A. ;   et al.
2008-01-31
Macrocyclic pyrimidines, their production and use as pharmaceutical agents
Grant 7,312,225 - Luecking , et al. December 25, 2
2007-12-25
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
Grant 7,291,624 - Brumby , et al. November 6, 2
2007-11-06
CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
Grant 7,288,547 - Lucking , et al. October 30, 2
2007-10-30
Composition Comprising Antiprogestins And Pure Antiestrogens For Prophylaxis And Treatment Of Hormone-dependent Diseases
App 20070238714 - FUHRMANN; Ulrike ;   et al.
2007-10-11
Macrocyclic anilinopyrimidines with substituted sulphoximine as selective inhibitors of cell cycle kinases
App 20070191393 - Lucking; Ulrich ;   et al.
2007-08-16
Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamates
Grant 7,244,762 - Hillisch , et al. July 17, 2
2007-07-17
Compound and a composition including such a compound
Grant 7,235,561 - Brumby , et al. June 26, 2
2007-06-26
New effector conjugates, process for their production and their pharmaceutical use
App 20070088060 - Berger; Markus ;   et al.
2007-04-19
Thiazolidinones, their production and use as pharmaceutical agents
App 20070037862 - Siemeister; Gerhard ;   et al.
2007-02-15
Metasubstituted thiazolidinones, their manufacture and use as a drug
App 20070015759 - Schulze; Volker Klaus ;   et al.
2007-01-18
Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
App 20070010566 - Prien; Olaf ;   et al.
2007-01-11
New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
App 20070010565 - Prien; Olaf ;   et al.
2007-01-11
Use of CDK II inhibitors for birth control
App 20060252748 - Lindenthal; Bernhard ;   et al.
2006-11-09
Effector conjugates, process for their production and their pharmaceutical use
Grant 7,129,254 - Berger , et al. October 31, 2
2006-10-31
N-aryl-sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
App 20060229325 - Luecking; Ulrich ;   et al.
2006-10-12
Thiazolidinones, their production and use as pharmaceutical agents
App 20060223833 - Schulze; Volker ;   et al.
2006-10-05
Antitumoral18a-homoestra-1,3,5(10)-trien-3yl 2-substituted sulfamates
App 20060211670 - Hillisch; Alexander ;   et al.
2006-09-21
2-Substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action
App 20060160782 - Hillisch; Alexander ;   et al.
2006-07-20
Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamates
App 20060154985 - Hillisch; Alexander ;   et al.
2006-07-13
Substituted 2-anilinopyrimidines as cell-cycle-kinase or receptor-tyrosine-kinase inhibitors, their production and use as pharmaceutical agents
App 20060111378 - Cleve; Arwed ;   et al.
2006-05-25
Thiazolidinones and the use therof as polo-like kinase inhibitors
App 20060079503 - Schwede; Wolfgang ;   et al.
2006-04-13
Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
App 20050176743 - Luecking, Ulrich ;   et al.
2005-08-11
New effector conjugates, process for their production and their pharmaceutical use
App 20050026971 - Berger, Markus ;   et al.
2005-02-03
Composition comprising progesterone-receptor antagonists and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
App 20050014736 - Fuhrmann, Ulrike ;   et al.
2005-01-20
Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
App 20040242551 - Fuhrmann, Ulrike ;   et al.
2004-12-02
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
App 20040224966 - Brumby, Thomas ;   et al.
2004-11-11
Macrocyclic pyrimidines, their production and use as pharmaceutical agents
App 20040209895 - Luecking, Ulrich ;   et al.
2004-10-21
3,5-Diamino-1,2,4-triazoles as kinase inhibitors
App 20040186288 - Kruger, Martin ;   et al.
2004-09-23
Substituted N-(1,4,5,6,-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents
App 20040186156 - Kruger, Martin ;   et al.
2004-09-23
Human heparanase-related polypeptide and nucleic acid
App 20040161745 - Siemeister, Gerhard ;   et al.
2004-08-19
Combinations and compositions which interfere with VEGF/ VEGF and angiopoietin/ Tie receptor function and their use (II)
App 20040147449 - Siemeister, Gerhard ;   et al.
2004-07-29
Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents
Grant 6,747,046 - Kruger , et al. June 8, 2
2004-06-08
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
App 20040102630 - Brumby, Thomas ;   et al.
2004-05-27
Use of antiprogestins for the induction of apoptosis in a cell
App 20040072811 - Hoffmann, Jens ;   et al.
2004-04-15
CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
App 20040063737 - Lucking, Ulrich ;   et al.
2004-04-01
Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
App 20040048841 - Hoffmann, Jens ;   et al.
2004-03-11
Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents
App 20030212121 - Kruger, Martin ;   et al.
2003-11-13
Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use
App 20030055006 - Siemeister, Gerhard ;   et al.
2003-03-20
Use and compositions of antiprogestins for treatment of prostate diseases
App 20030013694 - Hoffmann, Jens ;   et al.
2003-01-16
Aryl-substituted indirubin derivatives, their production and use
App 20020132792 - Prien, Olaf ;   et al.
2002-09-19
Sulfur-containing indirubin derivatives, their production and use
App 20020107404 - Prien, Olaf ;   et al.
2002-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed